Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in GEHC — GE HealthCare Technologies Inc.

CIK 861177 NEW YORK, NY
Back to GEHC Full portfolio

Position in GEHC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$162,674,562
-$16,785,373 QoQ
Shares Held
2,541,393
+0.8% QoQ
Ownership
0.559%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#28
of 1,222 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 46% Shared 0% None 54%

Common Shares in GEHC Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,748,157,927 across 62 Medical Devices names. GEHC ranks #6 (3.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 12,835,753 $1,164,716,222
2 SYK
Stryker Corp
 2,689,376 $846,723,135
3 DXCM
Dexcom Inc
 11,261,876 $758,487,343
4 BSX
Boston Scientific Corp
 13,091,481 $558,744,402
5 EW
Edwards Lifesciences Corp
 5,488,643 $496,502,640
6 GEHC
GE HealthCare Technologies Inc.
This page 		2,541,393 $162,674,562
7 ZBH
Zimmer Biomet Holdings, Inc.
 1,457,553 $125,480,733
8 BIO
Bio-Rad Laboratories, Inc.
 418,884 $122,988,525

All Filings in GEHC

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $162,674,562 2,541,393
2026-03-31 $179,459,935 2,521,213
2025-12-31 $204,312,962 2,491,014
2025-09-30 $190,901,867 2,541,969
2025-06-30 $222,842,476 3,008,539
2025-03-31 $268,684,149 3,329,007
2024-12-31 $259,955,999 3,325,096
2024-09-30 $272,982,427 2,908,710
2024-06-30 $227,354,814 2,917,798
2024-03-31 $174,585,467 1,920,421
2023-12-31 $120,112,206 1,553,443
2023-09-30 $99,159,586 1,457,372
2023-06-30 $103,608,372 1,275,337
2023-03-31 $104,615,891 1,275,337